J Neurol Surg A Cent Eur Neurosurg 2013; 74(05): 307-312
DOI: 10.1055/s-0033-1341413
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Treatment of Cystic Craniopharyngioma by Endocavitary Instillation of Yttrium90 Radioisotope—Still a Valuable Treatment Option

Dimitri Vanhauwaert
1   Department of Neurosurgery, UZ Gent, Gent, Belgium
,
Giorgio Hallaert
1   Department of Neurosurgery, UZ Gent, Gent, Belgium
,
Edward Baert
1   Department of Neurosurgery, UZ Gent, Gent, Belgium
,
Dirk Van Roost
1   Department of Neurosurgery, UZ Gent, Gent, Belgium
,
Jean-Pierre Kalala Okito
1   Department of Neurosurgery, UZ Gent, Gent, Belgium
,
Jacques Caemaert
1   Department of Neurosurgery, UZ Gent, Gent, Belgium
› Institutsangaben
Weitere Informationen

Publikationsverlauf

15. Februar 2012

20. Dezember 2012

Publikationsdatum:
22. März 2013 (online)

Preview

Abstract

Craniopharyngiomas are a challenging pathology in neurosurgery because of their anatomic localization in the (supra)sellar region and their contact with diencephalic structures around the third ventricle. Among the different treatment modalities, stereotactic intracavitary treatment by instillation of yttrium90 radioisotope is a minimally invasive technique of particular use in the treatment of cystic or partially cystic craniopharyngiomas. It can be performed under local anesthesia during a short hospitalization and has a long-lasting effect. This treatment can be repeated or used in combination with other treatment modalities such as microsurgery, endoscopy, conformal external radiation therapy, or stereotactic radiosurgery. Thus, this old and perhaps almost forgotten treatment option is still valuable in the treatment of cystic craniopharyngiomas.